Svante Launches World's First Commercial Gigafactory for Carbon Capture & Removal Filters
Svante Technologies Inc. (Svante), a global leader in carbon capture and removal technologies, has officially completed the commissioning of its new Centre of Excellence for Carbon Capture and Removal – Redwood manufacturing Facility (Redwood) in Burnaby, British Columbia. This milestone marks the launch of the world's first gigafactory dedicated to producing commercial-scale carbon capture and removal filters designed to trap CO2 directly from industrial emissions and the atmosphere, and with the mindset of high-volume automation and product standardization to lower the manufacturing cost.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513713072/en/
Claude Letourneau, President & CEO, Svante Group opens the Svante Grand Opening 2025 event, "GO25" with a speech about how to move the carbon management industry forward. This two-day event celebrates the commissioning of Svante's gigafactory in Vancouver, BC, Canada, which will manufacture the company's filters for carbon capture and direct air capture.
The Redwood Facility spans 141,000 square feet and is equipped to manufacture enough solid sorbent-based filters to capture up to 10 million tonnes of CO2 annually, equivalent to the emissions of more than 27 million cars. Svante's patented structured sorbent filters, coated with metal-organic framework (MOF), represent a next-generation solution for managing industrial carbon emissions.
"Today, we are making history," said Claude Letourneau, President & CEO of Svante. "This gigafactory is a critical step forward in building the infrastructure necessary to scale up the carbon management industry and to build a marketplace for physical CO2. This first-of-a-kind manufacturing facility is a demonstration of what's possible when technology and climate ambition align to lend nature a hand in managing global CO2 emissions."
Svante is currently focusing on biogenic carbon dioxide removal (CDR) sectors like pulp and paper, ethanol production, and waste-to-energy, where carbon concentrations in post-combustion flue gas are higher, and capture costs are lower to generate CDR credits. Capturing the emissions from other industries, such as cement, steel, and fossil fuels, is an essential part of a sustainable energy transition, and the commissioning of Redwood shows that Svante is stepping up to the challenge.
Letourneau added, "We're also proud to launch this transformative manufacturing facility in Canada, which allows us to bring the supply chain to our shores and bring carbon management solutions closer to the needs of emitting industries in North America."
The facility's launch follows a US $145 million capital investment and is supported by a roster of strategic investors, including Chevron New Energies, Temasek, M&G, Canada Growth Fund, United Airlines Ventures, Samsung, GE Vernova, and more. Svante anticipates the need for additional gigafactories like Redwood in the next decade to keep pace with global carbon management market demand.
Svante’s technology is already powering several major carbon capture pilot projects, including installations at Chevron’s Kern River asset in the San Joaquin Valley in California. Additionally, its earlier work with Lafarge Holcim on Project CO2MENT continues to demonstrate effective carbon capture at Lafarge’s Richmond Cement Plant in British Columbia, Canada. In addition to serving the post-combustion or “point source” carbon capture market, Svante also manufactures filters for the leading direct air capture company, Climeworks, as part of their latest Gen 3 DAC technology, which Climeworks says cuts the cost of regenerative energy in half and doubles the CO2 capture volumetric capacity.
With its breakthrough approach and global manufacturing ambitions, Svante is setting a new benchmark for engineered carbon capture and removal solutions. This facility is solidifying investor, customer, and partner confidence in Svante's ability to deliver commercial projects and products today at scale and demonstrating that the company is strategically positioned for long-term success.
About Svante
Svante is a purpose-driven, leading carbon capture and removal solutions provider. The Vancouver, Canada-based company manufactures nanoengineered filters and modular rotary contactor machines that capture and remove CO2 from industrial emissions and the air in an environmentally responsible manner. Svante is on TIME & Statista’s Top Greentech Companies of 2025, the 2025 Global Cleantech 100, the XPRIZE Foundation’s XB100 – World’s Top 100 Deep Tech Companies, and was ranked second among private companies in the Corporate Knights’ Future 50 Fastest Growing Sustainable Companies.
For more information, visit www.svanteinc.com and follow Svante on LinkedIn at www.linkedin.com/svantesolutions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250513713072/en/
Contacts
Media:
Colleen Nitta, Director, Marketing & Communications
cnitta@svanteinc.com
+1-604-970-2813
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corona Global Named Most Valuable Beer Brand in Kantar BrandZ Rankings for Second Consecutive Year15.5.2025 07:01:00 EEST | Press release
Corona has been recognized as the most valuable beer brand in the world for the second consecutive year in Kantar's BrandZ 2025 Most Valuable Global Brands report, released today. Eight out of the 10 most valuable global beer brands belong to AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD), according to the report ranking the top brands in the world. In 2024 AB InBev produced all-time high revenue and 15% Underlying EPS growth. The year marked double-digit growth for Corona outside of its home market of Mexico and triple-digit growth of its no-alcohol brand Corona Cero. Corona Cero is the first beer brand to sponsor the Olympic Games making its debut in Paris 2024. In 2025, Corona is celebrating its 100-year anniversary with events all over the world through its “Corona 100” platform. Corona is followed by Budweiser, the second most valuable beer brand in the world. Michelob ULTRA moved up one spot to #5 amongst beer brands globally. Michelob ULTRA has also been named the winner
Forrester Opens Nominations For Its 2025 B2B Awards In EMEA And APAC15.5.2025 07:00:00 EEST | Press release
Forrester (Nasdaq: FORR) today opened calls for nominations for its 2025 B2B Return On Integration Honors and B2B Programs Of The Year Awards in Asia Pacific (APAC) and Europe, Middle East, and Africa (EMEA). These awards will recognize B2B organizations based in both regions for achieving functional excellence and outstanding alignment across marketing, sales, and product — the B2B revenue engine — to improve customer experience and drive growth. Nominations for both award categories are open to organizations of all sizes in each region. B2B leaders across APAC and EMEA — including chief marketing officers, chief sales officers, chief product officers, and other marketing, sales, and product leaders — are invited and encouraged to apply. To be eligible, programs need to be developed by leaders and teams based in the APAC or EMEA regions. The nomination criteria for the two awards are as follows: B2B Return On Integration (ROI) Honors. These awards showcase organizations that have achi
Microba Announces Landmark GI Study Results From Over 4,600 Patients15.5.2025 05:12:00 EEST | Press release
Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), a precision microbiome company, today announces preliminary results from the analysis of over 4,600 MetaXplore™ GI Plus test results, a comprehensive test for the assessment and management of lower gastrointestinal disorders, spanning symptoms including chronic pain, bloating, constipation, or diarrhea. This study demonstrates that MetaXplore can support clinicians to identify and address underlying gut issues that often go undetected by conventional testing. In over 70% of cases, the test revealed findings, such as abnormalities in gut bacteria, signs of infection, markers of inflammation or insufficiency that could inform targeted treatment strategies. Further, two-thirds of MetaXplore patients in a separate study of follow up survey results reported improvement of symptoms after their care was guided by the test results. This press release features multimedia. View the full release here: https://www.businesswire.
Bloomstreet Enters into Strategic Partnership Agreement with Google Israel for Market Expansion in Japan15.5.2025 05:00:00 EEST | Press release
Bloomstreet Inc. (Headquarters: Chuo-ku, Tokyo; President & CEO: Junichi Takayama; hereinafter “Bloomstreet”), a company that supports overseas enterprises entering the Japanese market, is pleased to announce a strategic partnership agreement with Google Israel Ltd. (Headquarters: Tel Aviv District; Country Manager: Barak Regev; hereinafter “Google Israel”). This partnership aims to support Israeli companies that operate globally with Google Ads and are seeking to expand into the Japanese market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250514387485/en/ How do Bloomstreet and Google Israel collaborate? The partnership between Bloomstreet and Google Israel is designed to support Israeli companies seeking to expand into the Japanese market by optimizing their website UI/UX, thereby enhancing the effectiveness of their Google Ads campaigns. Background of the Partnership Known as a "Start-up Nation," Israel is home to many
Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience15.5.2025 04:11:00 EEST | Press release
Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that using open source codes integrated in the company’s broader propriety drug discovery platform, ALEMBIC™, helped to identify senescent neurons in a new study that found senescent neurons drive chronic pain with injury and age.1 Senescent cells, often called “zombie” cells, arise as the results of cellular stress and damage. These senescent cells do not die but undergo cellular changes, including secreting pro-inflammatory factors, thereby potentially contributing to inflammatory responses within the body.1 The study, led by Stanford University scientists, Vivianne Tawfik, MD, PhD, and Lauren Donovan, PhD, and co-authored by Rubedo team members, including Chief Scientific Officer Marco Quarta, PhD, and Chief Technology Officer Alex Laslavic, was published in the May 14th edition of Nat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom